90 related articles for article (PubMed ID: 21343836)
1. Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer.
Fujiwara Y; Furukawa K; Shimada Y; Iida T; Shiba H; Uwagawa T; Misawa T; Ohashi T; Yanaga K
Pancreas; 2011 May; 40(4):600-7. PubMed ID: 21343836
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
3. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
Fujiwara Y; Furukawa K; Haruki K; Shimada Y; Iida T; Shiba H; Uwagawa T; Ohashi T; Yanaga K
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):731-9. PubMed ID: 21484229
[TBL] [Abstract][Full Text] [Related]
4. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination.
Kobayashi H; Yagyu T; Kondo T; Kurita N; Inagaki K; Haruta S; Kawaguchi R; Kitanaka T; Sakamoto Y; Yamada Y; Kanayama N; Terao T
Cancer Res; 2005 Nov; 65(22):10464-71. PubMed ID: 16288038
[TBL] [Abstract][Full Text] [Related]
5. Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.
Sohma I; Fujiwara Y; Sugita Y; Yoshioka A; Shirakawa M; Moon JH; Takiguchi S; Miyata H; Yamasaki M; Mori M; Doki Y
Cancer Genomics Proteomics; 2011; 8(1):39-47. PubMed ID: 21289336
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
Furukawa K; Ohashi T; Haruki K; Fujiwara Y; Iida T; Shiba H; Uwagawa T; Kobayashi H; Yanaga K
Cancer Lett; 2011 Jul; 306(1):92-8. PubMed ID: 21482023
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
8. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
9. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Janus SC; Weurtz B; Ondrey FG
Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer.
Gocho T; Uwagawa T; Furukawa K; Haruki K; Fujiwara Y; Iwase R; Misawa T; Ohashi T; Yanaga K
Cancer Lett; 2013 Jun; 333(1):89-95. PubMed ID: 23348695
[TBL] [Abstract][Full Text] [Related]
11. New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.
Horiuchi T; Uwagawa T; Shirai Y; Saito N; Iwase R; Haruki K; Shiba H; Ohashi T; Yanaga K
J Surg Res; 2016 Nov; 206(1):1-8. PubMed ID: 27916347
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
14. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
Zhang D; Qiu L; Jin X; Guo Z; Guo C
Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice.
Haruki K; Shiba H; Fujiwara Y; Furukawa K; Iwase R; Uwagawa T; Misawa T; Ohashi T; Yanaga K
Dig Dis Sci; 2013 Jan; 58(1):123-31. PubMed ID: 22806547
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
Shirai Y; Shiba H; Iwase R; Haruki K; Fujiwara Y; Furukawa K; Uwagawa T; Ohashi T; Yanaga K
Cancer Lett; 2016 Jan; 370(2):177-84. PubMed ID: 26546875
[TBL] [Abstract][Full Text] [Related]
18. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
Thaker PH; Yazici S; Nilsson MB; Yokoi K; Tsan RZ; He J; Kim SJ; Fidler IJ; Sood AK
Clin Cancer Res; 2005 Jul; 11(13):4923-33. PubMed ID: 16000591
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion.
Mino K; Ozaki M; Nakanishi K; Haga S; Sato M; Kina M; Takahashi M; Takahashi N; Kataoka A; Yanagihara K; Ochiya T; Kamiyama T; Umezawa K; Todo S
Cancer Sci; 2011 May; 102(5):1052-8. PubMed ID: 21288284
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model.
Furukawa K; Iida T; Shiba H; Fujiwara Y; Uwagawa T; Shimada Y; Misawa T; Ohashi T; Yanaga K
Oncol Rep; 2010 Oct; 24(4):843-50. PubMed ID: 20811662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
